Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing

Tropical Medicine and International Health

Volumn 13, Issue 1, 2008, Pages 31-40

  Baethgen, L F ^a,b   Weidlich, L ^a,b   Moraes, C ^b   Klein, C ^b   Nunes, L S ^b   Cafrune, P I ^a,b   Lemos, A P ^c   Rios, S S ^d   Abreu, M F ^d   Kmetzsch, C ^e   Sperb, A F ^e   Riley, L W ^f   Rossetti, M L R ^b,g   Zaha, A ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Fundacao Estadual de Producao e Pesquisa em Saude   (Brazil)

^c INSTITUTO ADOLFO LUTZ   (Brazil)

^d Inst de Pesquisas Biologicas Laboratorio Central do Estado do Rio Grande do Sul (IPB/LACEN/RS)   (Brazil)

^e Divisão de Atenção à Saúde Secretaria da Saúde do Estado do Rio Grande do Sul   (Brazil)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Brazil; Epidemiology; Molecular characterization; Neisseria meningitidis; Rio Grande do Sul

Indexed keywords

BACTERIAL DISEASE; BACTERIUM; COHORT ANALYSIS; EPIDEMIC; EPIDEMIOLOGY; MENINGITIS;

ARTICLE; BRAZIL; COHORT ANALYSIS; CONTROLLED STUDY; EPIDEMIC; EPIDEMIOLOGICAL DATA; INFECTION RATE; MENINGOCOCCOSIS; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; RETROSPECTIVE STUDY;

BACTEREMIA; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BRAZIL; CHILD, PRESCHOOL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; PREVALENCE; SEASONS; SEQUENCE ANALYSIS, DNA; SEROTYPING;

BRAZIL; DENMARK; EURASIA; EUROPE; FRANCE; NORTHERN EUROPE; PARANA; RIO GRANDE DO SUL; SANTA CATARINA; SCANDINAVIA; SOUTH AMERICA; WESTERN EUROPE;

NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS SEROGROUP B;

EID: 39449098760     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2007.01970.x     Document Type: Article

References (61)

1. Aguilera JF, Perrocheau A, Meffre C et al. (2002) Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe 2000. Emerging Infectious Diseases 8, 761 767.
2. Ashton FE Caugant DA (2001) The panmitic nature of Neisseria meningitidis serogroup B during a period of endemic disease in Canada. Canadian Journal of Microbiology 47, 283 289.
3. Baethgen LF, Moraes C, Weidlich L et al. (2003) Direct-test PCR for detection of meningococcal DNA and its serogroup characterization: standardization and adaptation for use in a public health laboratory. Journal of Medical Microbiology 52, 793 799.
4. Barata RB (2004) The impact of mass vaccination on meningococcal disease in the 1970s epidemic in Brazil. Cadernos de Saúde Pública (Reports in Public Health) 20, 1762 1763.
5. Boras A, Jeren T, Sacchi CT et al. (2004) Establishment of an active laboratory-based surveillance for bacterial meningitis in Croatia and molecular characterization of Neisseria meningitidis isolates causing meningococcal disease that were collected in the year 2000, the first year of activity. Journal of Clinical Microbiology 42, 1803 1806.
6. Brasil. Ministério da Saúde (1999) Fundação Nacional de Saúde. Boletim Epidemiológico. Edição Especial. Ano III. Evolução temporal das doenças de notificação compulsória no Brasil de 1980 a 1998. Doença Meningocócica 9-10.
7. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde (2005) Guide to Epidemiological Survaillance, 6th edn. (Série A. Normas e Manuais Técnicos) (http://portal.saude.gov.br/ portal/arquivos/pdf/Guia_Vig_Epid_novo2.pdf) Ministério da Saúde, Brasília, pp. 861 (accessed 14 December 2007).
8. Brooks JL, Rosenqvist E, Bjune G et al. (1994) Compasisson of the class-1 outer membrane protein from B:15:P1.16 Neisseria meningitidis strains isolated from patients previously immunized with a serogroup B outer membrane protein vaccine in Norway. Microbial Pathogenesis 17, 425 430.
9. Campagne G, Schuchat A, Djibo S et al. (1999) Epidemiology of bacterial meningitis in Niamey, Niger 1981-96. Bulletin of the World Health Organization 77, 499 508.
10. Caugant DA (1998) Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 106, 505 525.
11. Caugant DA, Kristiansen B-E, Froholm LO et al. (1988) Clonal diversity of Neisseria meningitidis from a population of asyntomatic carriers. Infection and Immunity 56, 2060 2068.
12. Chiou CS, Liao JC, Liao TL et al. (2006) Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan. BMC Infectious Diseases 6, 25.
13. Cruz C, Pavez G, Aguilar E et al. (1990) Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile. Epidemiology and Infection 105, 119 126.
14. Danzig L (2006) Reverse vaccinology - in search of a genome-derived meningococcal vaccine. Vaccine 24, 11 12.
15. Donalisio MR, Kemp B, Rocha MM Ramalheira RM (2000) Fatality rate in the epidemiology of meningococcal disease: study in the region of Campinas, SP, Brazil 1993 to 1998. Revista de Saúde Pública 34, 589 595.
16. Dyet KH Martin DR (2005) Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic. Journal of Clinical Microbiology 43, 838 842.
17. Escosteguy CC, Medronho RA, Madruga R et al. (2004) Epidemiologic surveillance and evaluation of meningitis hospital care. Revista de Saúde Pública 38, 657 663.
18. Feavers IM, Gray SJ, Urwin R et al. (1999) Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak. Journal of Clinical Microbiology 37, 3883 3887.
19. de Filippis I Vicente AC (2005) Multilocus sequence typing and repetitive element-based polymerase chain reaction analysis of Neisseria meningitidis isolates in Brazil reveal the emergence of 11 new sequence types genetically related to the ST-32 and ST-41/44 complexes and high prevalence of strains related to hypervirulent lineages. Diagnostic Microbiology and Infectious Disease 53, 161 167.
20. de Filippis I, de Andrade CF, Silva L et al. (2007) PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004. Infection and Immunity 75, 3683 3685.
21. Frasch CE, Zollinger WD Poolman JT (1985) Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Reviews of Infectious Diseases 7, 504 510.
22. Giuliani MM, Adu-Bobie J, Comanducci M et al. (2006) A universal vaccine for serogroup B meningococcus. Proceedings of the National Academy of Sciences of the USA 103, 10834 10839.
23. Gottfredsson M, Diggle MA, Lawrie DI et al. (2006) Neisseria meningitidis sequence type and risk for death, Iceland. Emerging Infectious Diseases 12, 1066 1073.
24. IBGE. Instituto Brasileiro de Geografia e Estatística (2007) População. Contagem da população 2007. http://www.ibge.gov.br (accessed 14 December 2007).
25. Jensen ES, Berthelsen L, Lind I et al. (2002) Period prevalence and case fatality rate associated with distinctive clone complexes of Neisseria meningitidis serogroups B and C. European Journal of Clinical Microbiology and Infectious Diseases 21, 506 512.
26. Jensen ES, Schonheyder HC, Lind I et al. (2003) Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county. Journal of Medical Microbiology 52, 173 179.
27. Jessouroun E, da Silveira IF, Larangeira AP et al. (2004) Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock. Vaccine 22, 2617 2625.
28. Jolley KA, Chan MS Maiden MC (2004) mlstdbNet - Distributed multilocus sequence typing (MLST) databases. BMC Bioinformatics 5, 86.
29. Kyaw MH, Christie P, Jones IG Campbell H (2002) The changing epidemiology of bacterial meningitis and invasive non-meningitic bacterial disease in Scotland during the period 1983-99. Scandinavian Journal of Infectious Diseases 34, 289 298.
30. Law DK, Lorange M, Ringuette L et al. (2006) Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19). Journal of Clinical Microbiology 44, 2743 2749.
31. Lemos AP, Brandao AP, Gorla MC et al. (2006) Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001. Journal of Medical Microbiology 55, 751 757.
32. Lindsay AP, Hope V, Marshall RJ Salinger J (2002) Meningococcal disease and meteorological conditions in Auckland, New Zealand. Australian and New Zealand Journal of Public Health 26, 212 218.
33. Lingappa JR, Al-Rabeah AM, Hajjeh R et al. (2003) Serogroup W-135 meningococcal disease during the Hajj 2000. Emerging Infectious Diseases 9, 665 671.
34. Maiden MCJ, Bygraves JA, Feil E et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proceedings of the National Academy of Sciences of the United States of America 95, 3140 3145.
35. Mantese OC, Hirano J, Santos IC et al. (2002) Etiological profile of bacterial meningitis in children. Jornal de Pediatria 78, 467 474.
36. Martin DR, Ruijne N, McCallum L et al. (2006) The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB. Clinical and Vaccine Immunology 13, 486 491.
37. Murphy KM, O'Donnell KA, Higgins AB et al. (2003) Irish strains of Neisseria meningitidis: characterisation using multilocus sequence typing. British Journal of Biomedical Science 60, 204 209.
38. Nicolas P, Decousset L, Riglet V et al. (2001) Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerging Infectious Diseases 7, 849 854.
39. Nicolas P, Norheim G, Garnotel E et al. (2005) Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. Journal of Clinical Microbiology 43, 5129 5135.
40. Noronha CP, Baran M, Nicolai CC et al. (1997) Epidemiology of meningococcal disease in the city of Rio de Janeiro: changes after vaccination against B and C serogroups. Cadernos de saúde pública/ Ministério da Saúde, Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública 13, 295 303.
41. Paret G, Keller N, Barzilai A et al. (1999) Invasive meningococcal disease: patient and strain characteristics set new challenge for prevention and control. Infection 27, 261 264.
42. Peltola H (1983) Meningococcal disease: still with us. Reviews of Infectious Diseases 5, 71 91.
43. Poolman JT Abdillahi H (1988) Outer membrane protein serosubtyping of Neisseria meningitidis. European Journal of Clinical Microbiology & Infectious Diseases 7, 291 292.
44. Popovic T, Sacchi CT, Reeves MW et al. (2000) Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerging Infectious Diseases 6, 428 429.
45. Rosenqvist E, Hoiby EA, Wedege E et al. (1993) A new variant of subtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine. Microbial Pathogenesis 15, 197 205.
46. Rosenstein NE, Perkins BA, Stephens DS et al. (1999) The changing epidemiology of meningococcal disease in the United States 1992-1996. The Journal of Infectious Diseases 180, 1894 1901.
47. Schouls LM, van der Ende A, Damen M van de Pol I (2006) Multiple-locus variable-number tandem repeat analysis of Neisseria meningitidis yields groupings similar to those obtained by multilocus sequence typing. Journal of Clinical Microbiology 44, 1509 1518.
48. Schuchat A, Robinson K, Wenger JD et al. (1997) Bacterial meningitis in the United States in 1995. Active Surveillance Team. New England Journal of Medicine, 337, 970 976.
49. Skoczynska A, Konior R, Sadowy E et al. (2004) Identification of Neisseria meningitidis sequence type 66 in Poland. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 10, 848 850.
50. Stephens DS (2007) Conquering the meningococcus. FEMS Microbiology Reviews 31, 3 14.
51. Taha MK (2000) Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. Journal of Clinical Microbiology 38, 855 857.
52. Taha MK, Bichier E, Perrocheau A Alonso JM (2001) Circumvention of herd immunity during an outbreak of meningococcal disease could be correlated to escape mutation in the porA gene of Neisseria meningitidis. Infection and Immunity 69, 1971 1973.
53. Taha MK, Giorgini D, Ducos-Galand M Alonso JM (2004) Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. Journal of Clinical Microbiology 42, 4158 4163.
54. Tsolia MN, Theodoridou M, Tzanakaki G et al. (2003) The evolving epidemiology of invasive meningococcal disease: a two-year prospective, population-based study in children in the area of Athens. FEMS Immunology and Medical Microbiology 36, 87 94.
55. Tzeng Y-L Stephens DS (2000) Epidemiology and pathogenesis of Neisseria meningitidis. Microbes and Infection/Institut Pasteur 2, 687 700.
56. Wang VJ, Kuppermann N, Malley R et al. (2001) Meningococcal disease among children who live in a large metropolitan area 1981-1996. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 32, 1004 1009.
57. Ward J, Hanna JN, Bates JR Selvey LA (2000) Enhanced surveillance for meningococcal disease in Queensland in 1999. Communicable Diseases Intelligence 24, 332 335.
58. Wedege E, Hoiby EA, Rosenqvist E Froholm LO (1990) Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and Elisa. Journal of Medical Microbiology 31, 195 201.
59. Weiss PLD, Coplan P Guess H (2001) Epidemiology of bacterial meningitis among children in Brazil 1997-1998. Revista de Saúde Pública 35, 249 255.
60. WHO (1998) Control of epidemic meningococcal disease. WHO Practical Guidelines. 2nd edn, World Health Organization. http://www.who.int/emc- documents/meningitis/whoemcbac983.html (accessed 14 December 2007).
61. WHO (2007) Bacterial infections. Neisseria meningitidis: Vaccine - group B. http://www.who.int/vaccine_research/diseases/soa_bacterial/en/print.html (accessed 14 December 2007).